Overview

Dexmedetomidine on Microcirculation in Septic Shock

Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
Dexmedetomidine was found might be beneficial to sepsis. Dexmedetomidine were found to improve microcirculation in sepsis animal studies and non-sepsis patients. However, the effect of dexmedetomidine on microcirculation in septic shock patients is unknown.
Phase:
Phase 4
Details
Lead Sponsor:
Southeast University, China
Treatments:
Dexmedetomidine